PFIZER INC Disposal Group, Including Discontinued Operation, Costs of Goods Sold
PFIZER INC (PFE) reported Disposal Group, Including Discontinued Operation, Costs of Goods Sold of $2.00 million for the 9-month period ending 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold · last filed 2013-11-08
- PFIZER INC disposal group, including discontinued operation, costs of goods sold for the quarter ending 2013-09-29 was $0.00.
- PFIZER INC disposal group, including discontinued operation, costs of goods sold for the quarter ending 2013-06-30 was $0.00.
- PFIZER INC disposal group, including discontinued operation, costs of goods sold for the quarter ending 2013-03-31 was $2.00M, a 0.00% change year-over-year.
- PFIZER INC disposal group, including discontinued operation, costs of goods sold for the quarter ending 2012-12-31 was $1.00M.
- PFIZER INC disposal group, including discontinued operation, costs of goods sold for fiscal 2012 was $3.00M.
| Period end | Disposal Group, Including Discontinued Operation, Costs of Goods Sold 3 month | Disposal Group, Including Discontinued Operation, Costs of Goods Sold 6 month | Disposal Group, Including Discontinued Operation, Costs of Goods Sold 9 month | Disposal Group, Including Discontinued Operation, Costs of Goods Sold 12 month |
|---|---|---|---|---|
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $2.00M 10-Q · filed 2013-11-08 | $3.00M derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.00M 10-Q · filed 2013-08-09 | $3.00M derived: sum of 3 quarters · filed 2013-08-09 | $3.00M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $2.00M 10-Q · filed 2013-05-10 | $3.00M derived: sum of 2 quarters · filed 2013-05-10 | $3.00M derived: sum of 3 quarters · filed 2013-05-10 | $3.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.00M derived: sum of 2 quarters · filed 2013-02-28 | $1.00M derived: sum of 3 quarters · filed 2013-02-28 | $3.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $2.00M 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $2.00M 10-Q · filed 2012-08-09 | ||
| 2012-04-01 | $2.00M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |